Eiji Ichimura
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Peptidase Inhibition and Analysis
Papers in
-
- Cancer therapeutics and mechanisms 3
- Fibroblast Growth Factor Research 2
- Glycosylation and Glycoproteins Research 1
- Oncology 5
- Peptidase Inhibition and Analysis 2
- Lung Cancer Research Studies 1
- Co-authors
- Takashi Nakajima (3 shared papers)Toshikazu Nakamura (2 shared papers)Arafumi Maeshima (1 shared paper)Rika Goda (2 shared papers)Kiyohiro Nishikawa (4 shared papers)Toshio Fukuda (1 shared paper)Kenji Kashiwabara (1 shared paper)Tetsuya Shinozaki (1 shared paper)
- Journals
- Pathology International (2 papers)The Journal of Antibiotics (1 paper)Toxicology Letters (1 paper)International Journal of Cancer (1 paper)International Immunopharmacology (1 paper)
- Partner nations
- Japan
In The Last Decade
Eiji Ichimura
12 papers receiving 319 citations
Peers
Comparison fields: 5 of 56
- Hepatology 115
- Oncology 87
- Pharmacology 26
- Pulmonary and Respiratory Medicine 82
- Cancer Research 34
Countries citing papers authored by Eiji Ichimura
This map shows the geographic impact of Eiji Ichimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiji Ichimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiji Ichimura more than expected).
Fields of papers citing papers by Eiji Ichimura
This network shows the impact of papers produced by Eiji Ichimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiji Ichimura. The network helps show where Eiji Ichimura may publish in the future.
Co-authors
The 25 scholars most cited alongside Eiji Ichimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 179 | |
| 2 | 1998 | 48 | |
| 3 | 2006 | 35 | |
| 4 | 2017 | 18 | |
| 5 | 2013 | 13 | |
| 6 | 2006 | 12 | |
| 7 | 2006 | 9 | |
| 8 | 2005 | 9 | |
| 9 | 1999 | 5 | |
| 10 | 2017 | 3 | |
| 11 | Marked antitumor activity of NK012, 7-ethyl-10-hydroxycamptothecin-incorporating micellar nanoparticle, in liver metastatic tumor model of colorectal cancer | 2007 | 1 |
| 12 | 2004 | 1 |
About Eiji Ichimura
Eiji Ichimura is a scholar working on Molecular Biology, Oncology, Epidemiology, Hepatology and Organic Chemistry, having authored 12 papers that have together received 333 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (3 papers), Liver physiology and pathology (2 papers), Peptidase Inhibition and Analysis (2 papers), Fibroblast Growth Factor Research (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Cancer Mechanisms and Therapy (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Hepatology (115 citations), Oncology (87 citations), Pharmacology (26 citations), Pulmonary and Respiratory Medicine (82 citations) and Cancer Research (34 citations). Eiji Ichimura has collaborated with scholars based in Japan. Frequent co-authors include Takashi Nakajima, Toshikazu Nakamura, Arafumi Maeshima, Rika Goda, Kiyohiro Nishikawa, Toshio Fukuda, Kenji Kashiwabara, Tetsuya Shinozaki, Tetsunari Oyama and Mikio Doi. Their work appears in journals such as Pathology International, The Journal of Antibiotics, Toxicology Letters, International Journal of Cancer and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.